GROUP ONE TRADING, L.P. - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 492515951. A total of 4 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$110,000
-12.0%
32,400
-2.7%
0.00%0.0%
Q2 2018$125,000
-58.6%
33,300
-54.9%
0.00%
-66.7%
Q1 2018$302,000
-61.1%
73,800
-55.8%
0.00%
-40.0%
Q4 2017$777,000
-48.1%
167,000
-20.8%
0.01%
-64.3%
Q3 2017$1,497,000
+58.4%
210,800
+61.3%
0.01%
+40.0%
Q2 2017$945,000
+23.5%
130,700
+5.2%
0.01%
+11.1%
Q1 2017$765,000
-41.9%
124,200
-44.8%
0.01%
-30.8%
Q4 2016$1,317,000
+101.7%
224,800
+82.9%
0.01%
+85.7%
Q3 2016$653,000
+132.4%
122,900
+189.2%
0.01%
+133.3%
Q2 2016$281,000
+32.5%
42,500
-6.4%
0.00%0.0%
Q1 2016$212,000
-81.9%
45,400
-80.5%
0.00%
-78.6%
Q4 2015$1,174,000
+57.6%
232,500
+9.8%
0.01%
+40.0%
Q3 2015$745,000
-69.0%
211,700
-12.0%
0.01%
-70.6%
Q2 2015$2,401,000
+17.9%
240,600
+50.5%
0.03%
+6.2%
Q1 2015$2,036,000
-49.0%
159,900
-43.3%
0.03%
-46.7%
Q4 2014$3,992,000
+15.9%
282,100
+12.7%
0.06%
+13.2%
Q3 2014$3,443,000
+5.2%
250,400
+17.7%
0.05%
+6.0%
Q2 2014$3,273,000
-41.3%
212,800
-34.9%
0.05%
-46.8%
Q1 2014$5,574,000
-8.3%
327,100
-30.3%
0.09%
+2.2%
Q4 2013$6,080,000
+79.2%
469,500
+39.8%
0.09%
+41.5%
Q3 2013$3,392,000
+11.7%
335,800
-17.4%
0.06%
-13.3%
Q2 2013$3,037,000406,5000.08%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 282,100$3,992,0000.06%
SABBY MANAGEMENT, LLC 128$181,0000.01%
Citadel Advisors 108,400$1,534,0000.00%
SIMPLEX TRADING, LLC 91$16,0000.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders